Real-World (RW) treatment patterns in patients with T2DM newly initiated with antihyperglycemic (AHA) medications in the US

被引：0
|
作者：
Cai, Jennifer [1 ]
Burudpakdee, Chakkarin [2 ]
Divino, Victoria [2 ]
Fegade, Mayuresh [3 ]
机构：
[1] Janssen, Beerse, Belgium
[2] IMS Hlth, Danbury, CT USA
[3] Janssen Med Affairs, Bombay, Maharashtra, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-82
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
    Markus, Aniek F.
    Rijnbeek, Peter R.
    Kors, Jan A.
    Brusselle, Guy
    Burn, Edward
    Prieto-Alhambra, Daniel
    Verhamme, Katia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 322 - 323
  • [22] Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Wang, Liya
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Panettieri, Reynold A., Jr.
    Corren, Jonathan
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1140 - 1158
  • [23] Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
    Markus, Aniek
    Rijnbeek, Peter
    Kors, Jan
    Brusselle, Guy
    Burn, Edward
    Prieto-Alhambra, Daniel
    Verhamme, Katia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [24] Clinical Effectiveness of Canagliflozin 100mg in T2DM Patients-A Real-World Study
    Chakravorty, Saibal, Sr.
    Patel, Vikas Kumar
    DIABETES, 2019, 68
  • [25] Real-World Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study)
    Ratzki-Leewing, Alexandria
    Harris, Stewart B.
    Au, Natalie H.
    Webster-Bogaert, Susan
    Brown, Judith B.
    Reichert, Sonja M.
    Ryan, Bridget L.
    DIABETES, 2019, 68
  • [26] OLDER PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES (T2DM) EXPERIENCE MORE DELAYED TREATMENT WITH ORAL ANTIHYPERGLYCEMIC AGENTS COMPARED WITH YOUNGER PATIENTS
    Zhang, Q.
    Rajagopalan, S.
    Marrett, E.
    Radican, L.
    VALUE IN HEALTH, 2010, 13 (03) : A67 - A67
  • [27] Real-world treatment patterns and adherence of first-line anti-diabetic treatments among T2dm patients using Japanese claims data
    Wang, Jocelyn Ruoyi
    Patrick, Amanda
    Mattox, Pattra
    Jaksa, Ashley
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 313 - 314
  • [28] CURRENT REAL-WORLD TREATMENT PATTERNS IN SHOULDER TENDINOSIS PATIENTS IN THE US
    Parikh, N.
    Martinez, D.
    Winer, I
    Costa, L.
    Dua, D.
    Trueman, P.
    VALUE IN HEALTH, 2020, 23 : S222 - S222
  • [29] Real-World Treatment Patterns and Transfusion Burden Among US Patients with Newly Diagnosed Myelodysplastic Syndromes (MDS)
    Mukherjee, Sudipto
    Slabaugh, S. Lane
    Copher, Ronda
    Johnson, Jonathan
    Buzinec, Paul
    Mearns, Elizabeth S.
    BLOOD, 2019, 134
  • [30] Real-world 12-month outcomes of patients with type 2 diabetes mellitus (T2DM) treated with canagliflozin in a US managed care setting
    Chow, Wing
    Buysman, Erin
    Rupnow, Marcia
    Anderson, Amy
    Henk, Henry
    Fegade, Mayuresh
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S118 - S118
12345